Faculty Associates

Noll L. Campbell

Contact Information
Email: campbenl@purdue.edu
Phone: 317-630-2214
Fax: 317-630-8776
Homepage: Homepage
Assistant Professor for Pharmacy Practice

PubMed Listing
Google Scholar Listing

PDF icon View Vita


PharmD Butler University Pharmacy 2002

Research Interests

adverse cognitive effects of medications in older adults, geriatric pharmacotherapy

Teaching Interests

geriatric pharmacotherapy, dementia


2019 - National Institute on Aging
2019 - National Institute on Aging
2018 - Health Resources and Service Administration
2016 - Indiana State Department of Health
2015 - Agency for Healthcare Quality and Research

Selected Publications

Grossi CM, Richardson K, Fox C, Maidment I, SteelN, Loke YK, Arthur A, Myint PK, Campbell N,Boustani M, Robinson L, Brayne C, Matthews FE, Savva GM. Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study. BMC Geraitr. 2019 Oct 21; 19(1): 276. doi: 10.1186/s12877-019-1280-2.

Richardson K, Mattishent K, Loke YK, Steel N, Fox C, Grossi CM, Bennett K, Maidment I, Boustani M, Matthews FE, Myint PK, Campbell NL, Bryane C, Robinson L, Savva GM. History of benzodiazepine prescriptions and risk of dementia: possible bias due to prevalent users and covariate measurement timing in a nested case-control study. Am J Epidemiol. 2019. Jul 1; 188(7): 1228-1236.

Campbell NL, Holden R, Boustani MA. Preventing Alzheimer Disease by deprescribing anticholinergic medications. JAMA Intern Med 2019 Jun; doi; 10.1001/jamainternmed.2019.0676. PMID: 31233087.

Holden RJ, Campbell NL, Abebe E, Clark DO, Ferguson D, Bodke K, Boustani MA, Callahan CM; Brain Health Patient Safety Laboratory. Usability and feasibility of consumer-facing technology to reduce unsafe medication use by older adults. Res Social Adm Pharm. 2019 Feb 26. pii: S1551-7411(19)30033-6. doi: 10.1016/j.sapharm.2019.02.011. [Epub ahead of print] PMID: 30853507.

Campbell NL, Solid CA, Boustani MA. Anticholinergics and dementia: the importance of patient education. Aging Today 2018; 39:5.

Holden, R.J., Srinivas, P., Campbell, N.L., Clark, D.O., Bodke, K.S., Hong, Y., Boustani, m.A., Ferguson, D., Callahan, CM.M (2018, in press). Understanding older adults' medication decision making and behavior: A study on over-the-counter (OTC) anticholinergic mediations. Research in Social and Administrative Pharmacy. 2018; in press. doi: 10.1016/j.sapharm.2018.03.002.

Fowler NR, Campbell NL, Pohl GM, Munsie LM, Kirson NY, Desai U, Treischman EJ, Meiselbach MK, Andrews JS, Boustani MA. One-year effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study. J Am Geriatr Soc. 2018; 66(5): 969-975.

Ricahrdson K, Fox C, Maidment I, Stell N, Loke YK, Arthur A, Myint PK, Grossi C, Mattishent K, Bennett K, Campbell NL, Boustani M, Robinson L, Brayne C, Matthews F, Savva G. The association between up to 20 year history of anticholinergic medication use and dementia incidence varies by drug class: A nested case-control study using the Clinical Practice Research Datalink. BMJ 2018; Apr 24;361:k1315. doi: 10.1136/bmj.k1315. pMID: 29695481.

Campbell NL, Lane KA, Gao S, Boustani M, Unverzagt F. Anticholinergics increase transition from normal cognition to mild cognitive impairment in community-dwelling older adults. Pharmacotherapy 2018 May; 38(5): 511-519. doi: 10.1002/phar.2106. Epub 2018 Apr 25. PMID: 29600808. https://doi.org/10.1002/phar.2106.

Wang S, Allen D, Kheir YN, Campbell NL, Khan B. Aging and Post-Intensive Care Syndrome (PICS): A Critical Need for Geriatric Psychiatry. Am J Geriatr Psychiatry 2017, 10.1016/j.jagp.2017.05.016.

Report a Problem